Condition
Irritable Bowel Syndrome (IBS-C)
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (1)
P 4 (1)
Trial Status
Not Yet Recruiting2
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07662083Not ApplicableNot Yet RecruitingPrimary
Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C
NCT07431957Phase 4Not Yet Recruiting
"Efficacy and Safety of Linaclotide in Chronic Constipation"
NCT00171431Phase 3Terminated
The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)
Showing all 3 trials